Nanoparticle-mediated delivery of pioglitazone enhances therapeutic neovascularization in a murine model of hindlimb ischemia.
about
Sphingolipids: a potential molecular approach to treat allergic inflammationNanoparticles for Cardiovascular Imaging and Therapeutic Delivery, Part 1: Compositions and FeaturesA holistic approach to targeting disease with polymeric nanoparticlesNanoparticle-Mediated Targeting of Cyclosporine A Enhances Cardioprotection Against Ischemia-Reperfusion Injury Through Inhibition of Mitochondrial Permeability Transition Pore Opening.A New Therapeutic Modality for Acute Myocardial Infarction: Nanoparticle-Mediated Delivery of Pitavastatin Induces Cardioprotection from Ischemia-Reperfusion Injury via Activation of PI3K/Akt Pathway and Anti-Inflammation in a Rat ModelPositron emission tomography imaging of angiogenesis in a murine hindlimb ischemia model with 64Cu-labeled TRC105Pioglitazone, a PPARγ agonist, attenuates PDGF-induced vascular smooth muscle cell proliferation through AMPK-dependent and AMPK-independent inhibition of mTOR/p70S6K and ERK signaling.Nanoparticle-Mediated Delivery of Irbesartan Induces Cardioprotection from Myocardial Ischemia-Reperfusion Injury by Antagonizing Monocyte-Mediated Inflammation.Pioglitazone inhibits HIF-1α-dependent angiogenesis in rats by paracrine and direct effects on endothelial cellsPeroxisome proliferator activating receptor-γ and the podocyte.Re-assessing the enhanced permeability and retention effect in peripheral arterial disease using radiolabeled long circulating nanoparticles.Rosiglitazone-loaded nanospheres for modulating macrophage-specific inflammation in obesity.PPARγ activation inhibits cerebral arteriogenesis in the hypoperfused rat brain.Mixing of the old with the new: nanoparticle-mediated pioglitazone delivery to enhance therapeutic neovascularization.
P2860
Q21296721-95796E64-7C65-4F25-8F76-ED9DF55830F7Q26798426-6E464AC1-4145-4D95-A99A-924461A1E1C8Q26865163-F4D9D75D-4AA0-48E5-A5EC-5F6ED9634089Q27350484-00591633-5181-4539-B92E-C70B50D772C2Q28546468-5E22D161-72E3-4E4A-B71A-5726EB490C3BQ34759659-D08C4141-9AA3-415C-9DD3-5E632866E7B5Q36578665-7B8EB430-990C-4FC3-B185-7F88C92066DDQ37081749-2839C446-9863-4B9B-8357-FD703A57DEEBQ37707352-F5436002-D08A-4D42-BE2B-FBA21288EA34Q38815188-B1923303-B70E-4569-9FC7-EAAD83F51BF8Q38859160-CAE123B9-0377-4236-8C8B-ACDE563C91FFQ39136593-98FC6C67-D00C-451F-A43D-7F8393C91653Q40143324-097D9374-EE78-4548-92DA-8D433A633BF4Q43141220-3A935529-85CB-4ECA-B4D3-BFAAA3D9965B
P2860
Nanoparticle-mediated delivery of pioglitazone enhances therapeutic neovascularization in a murine model of hindlimb ischemia.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Nanoparticle-mediated delivery ...... ne model of hindlimb ischemia.
@en
Nanoparticle-mediated delivery ...... ne model of hindlimb ischemia.
@nl
type
label
Nanoparticle-mediated delivery ...... ne model of hindlimb ischemia.
@en
Nanoparticle-mediated delivery ...... ne model of hindlimb ischemia.
@nl
prefLabel
Nanoparticle-mediated delivery ...... ne model of hindlimb ischemia.
@en
Nanoparticle-mediated delivery ...... ne model of hindlimb ischemia.
@nl
P2093
P1476
Nanoparticle-mediated delivery ...... ne model of hindlimb ischemia.
@en
P2093
Kaku Nakano
Kenji Sunagawa
Kensuke Egashira
Ryoji Nagahama
Shokei Kim-Mitsuyama
Tetsuya Matoba
P304
P356
10.1161/ATVBAHA.112.253823
P407
P577
2012-08-09T00:00:00Z